---
figid: PMC3970295__jbm-21-8-g004
figtitle: Wnt signaling as a pathway to increase bone formation
organisms:
- Mus musculus
- Rattus norvegicus
- Oryctolagus cuniculus
- Ovis aries
- Homo sapiens
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Ovis aries
- Oryctolagus cuniculus
- Danio rerio
pmcid: PMC3970295
filename: jbm-21-8-g004.jpg
figlink: /pmc/articles/PMC3970295/figure/F4/
number: F4
caption: Wnt signaling as a pathway to increase bone formation. (A) Wnt signalling
  pathway in the inactive state, showing a ligand Wnt inhibited by a decoy secreted
  frizzled-related protein (sFRP), the co-receptor, lipoprotein receptor-related protein
  (LRP)5/6, bound by either inhibitory protein, sclerostin or dickkopf (Dkk), and
  glycogen synthase kinase (GSK)-3β in the active state, resulting in proteasomal
  degradation of β-catenin (see text for details). (B) Active Wnt signalling, with
  LRP5/6 engaging in receptor complex after Wnt binding, disruption of GSK-3β inhibitory
  complex, stabilization of β-catenin and its translocation to nucleus where it activates
  transcription. Letters 1 to 5 indicate possible target sites for drug development
  (see text).
papertitle: 'Bone Biology and Anabolic Therapies for Bone: Current Status and Future
  Prospects.'
reftext: T. John Martin. J Bone Metab. 2014 Feb;21(1):8-20.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9386646
figid_alias: PMC3970295__F4
figtype: Figure
redirect_from: /figures/PMC3970295__F4
ndex: 753c6e5c-dedb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3970295__jbm-21-8-g004.html
  '@type': Dataset
  description: Wnt signaling as a pathway to increase bone formation. (A) Wnt signalling
    pathway in the inactive state, showing a ligand Wnt inhibited by a decoy secreted
    frizzled-related protein (sFRP), the co-receptor, lipoprotein receptor-related
    protein (LRP)5/6, bound by either inhibitory protein, sclerostin or dickkopf (Dkk),
    and glycogen synthase kinase (GSK)-3β in the active state, resulting in proteasomal
    degradation of β-catenin (see text for details). (B) Active Wnt signalling, with
    LRP5/6 engaging in receptor complex after Wnt binding, disruption of GSK-3β inhibitory
    complex, stabilization of β-catenin and its translocation to nucleus where it
    activates transcription. Letters 1 to 5 indicate possible target sites for drug
    development (see text).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - SOST
  - KREMEN1
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - AXIN1
  - AXIN2
  - FRAT1
  - ADAR
  - DVL1P1
  - APC
  - PROC
  - CTNNB1
  - HNF4A
  - LRP6
  - LRP5
  - Wnt2
  - Sost
  - Kremen1
  - Axin1
  - Frat1
  - Apc
  - Ctnnb1
  - Lrp6
  - Lrp5
  - Shh
  - szl
  - tlc
  - sost
  - kremen1
  - apc
  - ctnnb1
  - elk4
  - lrp6
  - lrp5
  - Cancer
---
